| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Dominika Szl\\xc4\\x99zak, Marcin Ufnal, Adrian Drapa\\xc5\\x82a, Emilia Samborowska, Maria Wr\\xc3\\xb3be. Urinary excretion of asymmetric (ADMA) and symmetric (SDMA) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats. Amino acids vol issue 2023 36802034 |
urinary excretion of asymmetric (adma) and symmetric (sdma) dimethylarginine is positively related to nitric oxide level in tissues of normotensive and hypertensive rats. |
2023-02-21 |
2023-03-06 |
rat |
| Alena A Kozlova, Elena Rubets, Magdalini R Vareltzoglou, Natalia Jarzebska, Vinitha N Ragavan, Yingjie Chen, Jens Martens-Lobenhoffer, Stefanie M Bode-B\\xc3\\xb6ger, Raul R Gainetdinov, Roman N Rodionov, Nadine Bernhard. Knock-out of the critical nitric oxide synthase regulator DDAH1 in mice impacts amphetamine sensitivity and dopamine metabolism. Journal of neural transmission (Vienna, Austria : 1996) vol issue 2023 36792833 |
the enzyme dimethylarginine dimethylaminohydrolase 1 (ddah1) plays a pivotal role in the regulation of nitric oxide levels by degrading the main endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (adma). |
2023-02-15 |
2023-03-06 |
mouse |
| Hebatallah Husseini Attei. Co-supplementation of Vitamin K2 and Selenium Synergistically Improves Metabolic Status and Reduces Cardiovascular Risk Markers in Dyslipidemic Rabbits. Biological trace element research vol issue 2023 36696048 |
regarding cardiovascular risk markers, dyslipidemic rabbits received vitamin k2 concurrently with selenium displayed lower levels of atherogenic index (ldl/hdl), serum c-reactive protein, heart fatty acid-binding protein and asymmetric dimethylarginine as well as aortic ox-ldl, lipid peroxidation and calcium but higher levels of serum nitric oxide and aortic total antioxidants than un-treated ones. |
2023-01-25 |
2023-01-31 |
Not clear |
| Iwona Malicka, Helena Martynowicz, Piotr Dzi\\xc4\\x99giel, Marzenna Podhorska-Oko\\xc5\\x82\\xc3\\xb3w, Marek Wo\\xc5\\xbaniewski, Andrzej Szub. Asymmetric Dimethylarginine in an NMU-induced Rat Mammary Tumor Model. Anticancer research vol 43 issue 1 2022 36585195 |
asymmetric dimethylarginine (adma) is an endogenous inhibitor of nitric oxide (no) production and a newly discovered risk factor involved in endothelial dysfunction and adverse cardiovascular events. |
2022-12-30 |
2023-01-30 |
rat |
| Eleni Pagkopoulou, Stergios Soulaidopoulos, Niki Katsiki, Afroditi Malliari, Charalampos Loutradis, Asterios Karagiannis, Michael Doumas, Alexandros Garyfallos, George Kitas, Theodoros Dimitroula. The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study. Clinical rheumatology vol issue 2022 36534350 |
the role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study. |
2022-12-19 |
2023-01-30 |
Not clear |
| Shiyun Wang, Zixuan Deng, Hong Zhang, Rong Zhang, Dandan Yan, Xiaojiao Zheng, Weiping Jia, Cheng H. The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy. Cardiovascular diabetology vol 21 issue 1 2022 36461077 |
dimethylarginine dimethylaminohydrolase (ddah) 1 maintains the bioavailability of nitric oxide by degrading asymmetric dimethylarginine (adma). |
2022-12-02 |
2023-01-30 |
Not clear |
| Yukiko K Kaneko, Ami Morioka, Misaki Sano, Maho Tashiro, Naoya Watanabe, Nahoko Kasahara, Masato Nojiri, Chihiro Ishiwatari, Kentaro Ichinose, Akira Minami, Takashi Suzuki, Momoka Yamaguchi, Toshihide Kimura, Tomohisa Ishikaw. Asymmetric dimethylarginine accumulation under hyperglycemia facilitates \\xce\\xb2-cell apoptosis via inhibiting nitric oxide production. Biochemical and biophysical research communications vol 637 issue 2022 36395692 |
asymmetric dimethylarginine accumulation under hyperglycemia facilitates \xce\xb2-cell apoptosis via inhibiting nitric oxide production. |
2022-11-17 |
2023-01-30 |
mouse |
| Eleni Pagkopoulou, Stergios Soulaidopoulos, Eva Triantafyllidou, Charalampos Loutradis, Afrodite Malliari, George D Kitas, Alexandros Garyfallos, Theodoros Dimitroula. Asymmetric dimethylarginine correlates with worsening peripheral microangiopathy in systemic sclerosis. Microvascular research vol 145 issue 2022 36374797 |
asymmetric dimethylarginine (adma) is an endogenous nitric oxide (no) inhibitor and represents a novel biomarker for vascular dysfunction. |
2022-11-14 |
2023-01-30 |
Not clear |
| Wei-Jin Fang, Xiao-Mei Li, Xin-Ke Zhou, Yan Xion. Resveratrol improves diabetic cardiomyopathy by preventing asymmetric dimethylarginine-caused peroxisome proliferator-activated receptor-\\xce\\xb3 coactivator-1\\xce\\xb1 acetylation. European journal of pharmacology vol 936 issue 2022 36341883 |
asymmetric dimethylarginine (adma) as an endogenous inhibitor of nitric oxide synthases is associated with diabetic cardiovascular complications and has a cross-talk with lysine acetylation. |
2022-11-07 |
2023-01-30 |
rat |
| Abdullah Erdogan, Ercument Keskin, Murat Sambel, Cuma Mertogl. Assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: A prospective study. Revista internacional de andrologia vol issue 2022 35907768 |
assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: a prospective study. |
2022-07-30 |
2023-01-30 |
Not clear |
| Abdullah Erdogan, Ercument Keskin, Murat Sambel, Cuma Mertogl. Assessing the nitric oxide and asymmetric dimethylarginine levels in lifelong premature ejaculation: A prospective study. Revista internacional de andrologia vol issue 2022 35907768 |
to evaluate nitric oxide (no) and asymmetric dimethylarginine (adma) levels in men with premature ejaculation (pe), which is a common condition that adversely affects quality of life. |
2022-07-30 |
2023-01-30 |
Not clear |
| Wiebe M C Top, Philippe Lehert, Casper G Schalkwijk, Coen D A Stehouwer, Adriaan Koo. Effect of metformin on arginine and dimethylarginines in patients with advanced type 2 diabetes: A post hoc analysis of a randomized trial. Diabetes, obesity & metabolism vol issue 2022 35789192 |
to study the effect of metformin on plasma levels of arginine, asymmetric dimethylarginine (adma) and symmetric dimethylarginine (sdma), indicators of the nitric oxide pathway. |
2022-07-05 |
2023-01-27 |
Not clear |
| Yasmin T Mohamed, Ibrahim A Naguib, Ali A Abo-Saif, Mohammed H Elkomy, Badrah S Alghamdi, Wafaa R Mohame. Role of ADMA/DDAH-1 and iNOS/eNOS signaling in the gastroprotective effect of tadalafil against indomethacin-induced gastric injury. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie vol 150 issue 2022 35658250 |
inducible nitric oxide synthase/endothelial nitric oxide synthase (inos/enos) and asymmetric dimethylarginine/ dimethylarginine dimethylaminohydrolase-1 (adma/ddah-1) signaling are key players in gastric ulcer pathogenesis. |
2022-06-05 |
2023-01-27 |
rat |
| Clyde A Smith, Afshin Ebrahimpour, Lyudmila Novikova, Dominic Farina, Aaron O Bailey, William K Russell, Antrix Jain, Alexander B Saltzman, Anna Malovannaya, B V Venkataram Prasad, Liya Hu, Yohannes T Ghebr. Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors. Biochimica et biophysica acta. General subjects vol issue 2022 35472493 |
dimethylarginine dimethylaminohydrolase (ddah) is a cardiovascular enzyme expressed in cardiomyocytes, and other somatic cell types in one of two isotypes (ddah1 and ddah2) to metabolize asymmetric dimethylarginine (adma); a cardiovascular risk factor and competitive inhibitor of nitric oxide synthases (noss). |
2022-04-26 |
2023-01-27 |
Not clear |
| Juliane Hannemann, Julia Zummack, Jonas Hillig, Leonard Rendant-Gantzberg, Rainer B\\xc3\\xb6ge. Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood. Journal of clinical medicine vol 11 issue 4 2022 35207213 |
asymmetric dimethylarginine is an endogenous inhibitor of nitric oxide synthesis and a cardiovascular risk factor. |
2022-02-25 |
2023-01-27 |
human |
| Eslam E Elhawary, Seham F Khedr, Hala M Nagy, Mohamed H El-Bradey, Mohamed R Elshanshor. Correlation of Asymmetric Dimethyl Arginine Level to Sickle Retinopathy in Children With Sickle Cell Disease. Journal of pediatric hematology/oncology vol issue 2022 35180766 |
asymmetric dimethyl arginine (adma) is a competitive inhibitor of nitric oxide synthetase especially in l-arginine deficiency, which is the case in sickle cell disease (scd). |
2022-02-18 |
2023-01-27 |
Not clear |
| Juliane Hannemann, Patricia Siques, Lena Schmidt-Hutten, Julia Zummack, Julio Brito, Rainer B\\xc3\\xb6ge. Association of Genes of the NO Pathway with Altitude Disease and Hypoxic Pulmonary Hypertension. Journal of clinical medicine vol 10 issue 24 2021 34945057 |
chronic intermittent hypoxia leads to high-altitude pulmonary hypertension, which is associated with high asymmetric dimethylarginine (adma), an endogenous inhibitor of nitric oxide synthesis. |
2021-12-24 |
2023-01-26 |
Not clear |
| Neveen Tawfik Abed, Omima Mohamed Abdel Haie, Amira Ibrahim Mansour, Eman Rateb Abd Almonae. Relation of asymmetric dimethylarginine with pulmonary morbidities in neonatal respiratory distress syndrome. Journal of neonatal-perinatal medicine vol 14 issue 4 2021 33646184 |
asymmetric dimethyl arginine (adma) is an endogenous inhibitor of nitric oxide synthase (nos) is important in different diseases characterized by decreased nitric oxide (no) availability. |
2021-12-10 |
2023-01-30 |
Not clear |
| Pratishtha Chatterjee, Yeo-Jin Cheong, Atul Bhatnagar, Kathryn Goozee, Yunqi Wu, Matthew McKay, Ian J Martins, Wei L F Lim, Steve Pedrini, Michelle Tegg, Victor L Villemagne, Prita R Asih, Preeti Dave, Tejal M Shah, Cintia B Dias, Stephanie J Fuller, Heidi Hillebrandt, Sunil Gupta, Eugene Hone, Kevin Taddei, Henrik Zetterberg, Kaj Blennow, Hamid R Sohrabi, Ralph N Martin. Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults. Journal of neurochemistry vol 159 issue 2 2021 32679614 |
metabolites belonging to biogenic amine (creatinine, symmetric dimethylarginine, asymmetric dimethylarginine; adma, kynurenine, trans-4-hydroxyproline), amino acid (citrulline, proline, arginine, asparagine, phenylalanine, threonine) and acylcarnitine classes were observed to have positive correlations with plasma nf-l, suggesting a link between neurodegeneration and biological pathways associated with neurotransmitter regulation, nitric oxide homoeostasis, inflammation and mitochondrial function. |
2021-11-19 |
2023-01-26 |
human |
| Paulina Guerrero-Almaraz, Manuel Quiroz, Joseph H Reibenspies, Marcetta Y Darensbour. Linear and Bent Nitric Oxide Ligand Binding in an Asymmetric Butterfly Complex: Inorganic chemistry vol 60 issue 21 2021 34157221 |
linear and bent nitric oxide ligand binding in an asymmetric butterfly complex: two synthetic approaches to install metallodithiolate ligands on molybdenum centers using the synthons [mo |
2021-11-02 |
2023-01-26 |
Not clear |